These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38255717)

  • 41. Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease.
    Middeldorp JM
    Curr Top Microbiol Immunol; 2015; 391():289-323. PubMed ID: 26428379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
    Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
    PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-lymphocyte subsets and Th1/Th2 cytokines in convalescent patients with Epstein-Barr virus-associated aplastic anemia.
    Chen T; Chen Y; Bao W; Lu W
    Hematology; 2020 Dec; 25(1):11-16. PubMed ID: 31842718
    [No Abstract]   [Full Text] [Related]  

  • 44. Cytokine production in response to Epstein-Barr virus infection of peripheral blood mononuclear cells in vitro.
    Whittingham S; Naselli G; Harrison LC; Boyd AW; Cebon J; Jack I
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():259-64. PubMed ID: 8225395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4
    Adhikary D; Damaschke J; Mautner J; Behrends U
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
    Chiang NJ; Hou YC; Tan KT; Tsai HW; Lin YJ; Yeh YC; Chen LT; Hou YF; Chen MH; Shan YS
    Hepatol Int; 2022 Oct; 16(5):1137-1149. PubMed ID: 35780451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases.
    Cui X; Snapper CM
    Front Immunol; 2021; 12():734471. PubMed ID: 34691042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses.
    Serquiña AKP; Tagawa T; Oh D; Mahesh G; Ziegelbauer JM
    mBio; 2021 Dec; 12(6):e0290721. PubMed ID: 34781692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes
    SoRelle ED; Reinoso-Vizcaino NM; Horn GQ; Luftig MA
    Front Immunol; 2022; 13():1001145. PubMed ID: 36248899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
    Li X; Xiong F; Hu Z; Tao Q; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Dong K; Hua Y; Zhang W; Xu M; Long W; Xiao Y; Wang D
    J Transl Med; 2024 Jan; 22(1):90. PubMed ID: 38254099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy.
    Sharma S; Woods M; Mehta NU; Sauer T; Parikh KS; Schmuck-Henneresse M; Zhang H; Mehta B; Brenner MK; Heslop HE; Rooney CM
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O; Gillis S; Kabelitz D
    Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.
    Waldman WJ; Williams MV; Lemeshow S; Binkley P; Guttridge D; Kiecolt-Glaser JK; Knight DA; Ladner KJ; Glaser R
    Brain Behav Immun; 2008 Feb; 22(2):215-23. PubMed ID: 17845840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-α pathway.
    Burassakarn A; Srisathaporn S; Pientong C; Wongjampa W; Vatanasapt P; Patarapadungkit N; Ekalaksananan T
    Oral Oncol; 2021 Jun; 117():105279. PubMed ID: 33819809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Illuminating the in vitro effects of Epstein-Barr virus and vitamin D on immune response in multiple sclerosis patients.
    Teymoori-Rad M; Sahraian MA; Mokhtariazad T; Nejati A; Mozdabadi RSK; Amiri MM; Shokri F; Marashi SM
    J Neurovirol; 2021 Apr; 27(2):260-271. PubMed ID: 33666884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclosporine A induces Epstein-Barr virus reactivation in tree shrew (Tupaia belangeri chinensis) model.
    Shi N; Chen H; Lai Y; Luo Z; Huang Z; He G; Yi X; Xia W; Tang A
    Microbes Infect; 2023; 25(8):105212. PubMed ID: 37633512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study.
    Gosselin J; Flamand L; D'Addario M; Hiscott J; Stefanescu I; Ablashi DV; Gallo RC; Menezes J
    J Immunol; 1992 Jul; 149(1):181-7. PubMed ID: 1318897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab.
    Tischer-Zimmermann S; Bonifacius A; Santamorena MM; Mausberg P; Stoll S; Döring M; Kalinke U; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
    Front Immunol; 2023; 14():878953. PubMed ID: 37033971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha.
    Gosselin J; Flamand L; D'Addario M; Hiscott J; Menezes J
    J Clin Invest; 1992 Jun; 89(6):1849-56. PubMed ID: 1318324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.